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Abstract
Rationale: Aspiration is a common sequela post stroke as a result of oropharyngeal
dysphagia. It is primarily managed using the poorly empirically supported intervention
of thickened liquids. Where evidence is limited, clinicians may rely on clinical practice
guidelines to support decision making. The purpose of this systematic review and nar-
rative synthesis was to evaluate the evidentiary bases of recommendations made by
stroke clinical practice guidelines regarding the thickened liquids intervention.
Methods: A systematic review was conducted on stroke clinical guidelines retrieved
via searches conducted across a range of databases including Academic Search Com-
plete, CINAHL, MEDLINE, and the Cochrane Library as well as through association
websites. Guidelines were eligible for inclusion if they focused on adult stroke
populations, made recommendations relating to the thickened liquid intervention and
were published between January 2010 and December 2018. Four independent
reviewers rated methodological quality using the AGREE-II instrument. Intervention
recommendations were extracted and analysed using the Criteria for Levels of Evi-
dence Reported from the Canadian Stroke Best Practice Recommendations and a
novel framework examining the appropriateness of the supporting evidence.
Abbreviations: AGREE-II, The Appraisal of Guidelines for Research and Evaluation Second Edition; Australia 2017, The Stroke Foundation of Australia CPG; Cameroon 2013, SEEPD Program of
the Cameroon Baptist Convention Health Board, the Bamenda Coordinating Centre for Studies in Disability and Rehabilitation (BCCSDR), and ICDR-Cameroon of the University of Toronto CPG;
Canada 2015, Heart and Stroke Foundation (HSF-C)/Canadian Stroke Best Practices Advisory Committee CPG; Canada 2018, Heart and Stroke Foundation (HSF-C)/Canadian Stroke Best
Practices Advisory Committee CPG; CPGs, clinical practice guidelines; Germany 2013, German Nutrition Society (DGEM) German Society for Neurology, German Geriatric Society CPG; Ireland
2010, Irish Heart Foundation CPG; Philippines 2010, The Stroke Society of the Philippines CPG; PRISMA, Preferred Reporting of Items for Systematic Reviews; PWD, people with dysphagia; TL,
thickened liquids; Scotland 2010 #118, Scottish Intercollegiate Network (SIGN) CPG #118; Scotland 2010 #119, Scottish Intercollegiate Network (SIGN) CPG #119; UK 2013, National Institute
for Clinical Excellence (NICE) CPG; UK 2016, Royal College of Physicians (RCP) Intercollegiate Stroke Working Party CPG; USA 2010, Veterans Association/Department of Defence (VA/DOD)
CPG; USA 2016, American Heart Association (AHA)/American Stroke Association (ASA) CPG.
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Results: Thirteen clinical guidelines were included in the review. Methodological quality
was variable with seven rating as good-excellent overall. Thirty recommendations regard-
ing the intervention were extracted. Of these, 16 recommendations were classed as a rec-
ommendation to use the treatment and all guidelines made this recommendation. Much of
the evidence used to scaffold recommendations did not directly support the intervention.
Conclusions: Despite the limited evidence base for the thickened liquid intervention,
there was consensus among stroke guidelines in recommending it. This is despite lim-
ited empirical support. Furthermore, much of the evidence used to support recom-
mendations was not appropriate, suggesting less than satisfactory evidence-based
practices in formulating recommendations. In this case, clinical guidelines may not be
reliable decision-support tools for facilitating clinical decision making.
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1 | BACKGROUND
1.1 | The intervention of thickened liquids
Stroke is a significant cause of oropharyngeal dysphagia which is known
to increase the risk of malnutrition, dehydration, aspiration, pneumonia,
and mortality.1,2 It is estimated that approximately half of stroke
patients experience aspiration and one-third of these develop aspiration
pneumonia.3 Furthermore, pneumonia is responsible for up to one-third
of post-stroke deaths.4 It is hypothesized that the early detection and
treatment of aspiration is important for both individual patients and
health care providers, as successful management of aspiration decreases
medical complications and related health care expenditures including
length of hospital stay.5 It is widely accepted that swallowing thin liquids
can pose a challenge for people with dysphagia (PWD) including those
with dysphagia post-stroke, because they flow too quickly and can enter
the airway below the vocal cords.6 Consequently, aspiration is primarily
treated by recommending thickened liquids (TL). This is a technique
whereby a thickening agent is added to liquids to increase viscosity and
slow bolus speed.7 It is a common practice worldwide. Approximately
78% of speech and language therapists working with a range of clinical
populations and 97% of those working with people with stroke employ
the intervention.8-10 Despite this, the evidence to support TL is not
strong.11-15 While some recent systematic reviews indicate emerging
support,12,15 the evidence base remains limited and contradictory with
some reviewers even making a weak recommendation against its use.16
Decision support tools such as clinical practice guidelines (CPGs) may
therefore be especially useful for interventions such as TL.
1.2 | Clinical practice guidelines
CPGs are “systematically developed statements that assist clinicians to
provide appropriate evidence-based care” (p. 57).17 They typically focus
on specific conditions such as stroke or dementia and provide evidence
based recommendations regarding a range of interventions which are
supported by reviews and evaluations of research findings. They aim to
bridge the gap between research and practice and have complementary
goals of optimizing patient care, decreasing variation in clinical practice,
reducing costly, preventable mistakes, and adverse events.18,19 Well-
constructed CPGs based on the most up-to-date evidence can improve
the quality of clinical decision making.18 Clinicians tend to view them as
key sources of reliable guidance with as many as 78% of health care
professionals employing them.20 The use of CPGs by clinicians can be
interpreted as positive clinical behaviour, illustrating a commitment to
evidence based practice and, according to Hurdowar et al, as an indica-
tor of quality of care.17 Therefore, establishing the validity of CPG rec-
ommendations is important, perhaps especially in cases of interventions
which are poorly empirically supported.
Quality CPGs should reflect evidence based practice and thus contain
recommendations supported by current research evidence where present.
They should also ideally incorporate clinical expertise and patients' per-
spectives. This triad of evidence may be especially important in cases
where the “existing literature is ambiguous or conflicting or where scien-
tific data is lacking or an issue” (p. 6).21 The use of practice evidence rather
than research-based evidence to support CPG recommendations is not
unusual. A recent review of CPGs for preoperative care for surgical anti-
microbial prophylaxis, for example, found that most recommendations
were based on clinical experience.22 The increased emphasis on person-
centred care has seen a growth in patient evidence being incorporated
into decision support tools. A recent systematic review of decision aids by
Clifford et al however, suggests this area remains considerably underde-
veloped.23 In the case of the TL intervention, there are known palatability
issues with impacts on independence and quality of life and associated
treatment adherence issues.7,24 Such patient evidence should be reflected
by guidelines when making recommendations.
The evolution of CPGs as sources of reliable clinical information
has naturally resulted in research on guideline quality.25,26 Recent
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systematic reviews of stroke CPGs suggest some issues in this area
including regarding rigour of development.16,27 Navarro-Puerto et al,
for example, reported that the majority of ischaemic stroke CPGs
reviewed in their study, received an overall “would not recommend”
rating.27 There has been considerably less focus on assessing the qual-
ity of recommendations made within CPGs—specifically the eviden-
tiary bases of recommendations. Cosgrove et al's examination of
recommendations in a major psychiatry CPG showed that fewer than
half of the included studies supporting the recommendations met the
criteria for high quality. Furthermore, they identified that one-fifth of
the references were not congruent with the recommendations.28 As
stroke is the leading cause of long-term adult disability, the quality
and content of stroke CPGs may be especially pertinent especially as
organized stroke care has been shown to be beneficial and stroke evi-
dence continues to grow rapidly.17,29 If Cosgrove et al's findings were
to be replicated in stroke CPGs, questions regarding their role in
supporting clinical decision making would naturally ensue. Gandhi
et al argue that poor-quality CPGs can be detrimental to clinical prac-
tice.30 There is a risk that such CPGs may result in the dissemination
of inaccurate knowledge, be translated into poor clinical practice,
result in waste of resources, be potentially harmful to patients,19,30
and contrary to the overall aims of evidence-based practice generally.
1.3 | Study aims
The purpose of this systematic review and narrative synthesis is to
evaluate the evidentiary bases of stroke CPG recommendations
regarding the TL intervention.
2 | METHOD
There are no specific standardized reporting guidelines relating to sys-
tematic reviews of CPGs. To this end, relevant sections of the Pre-
ferred Reporting of Items for Systematic Reviews (PRISMA)
guidelines31 were referenced to standardize the conduct and
reporting of the review. The protocol for this review has not been
published elsewhere.
2.1 | Identification of CPGs
A search strategy was developed to identify all stroke CPGs that were
published between January 2010 and December 2018. For the pur-
poses of this study, stroke CPGs were defined as CPGs focused pri-
marily on the condition of stroke in both acute and chronic phases
and which made recommendations for the rehabilitation of the stroke
patient. The search strategies were based on the processes rec-
ommended by Moher et al (Appendix S1).31 Databases, stroke associ-
ation websites, and guideline websites were the main sources
searched (Appendix S2). Hand-searching of references of included
CPGs was also conducted. Where further information was required
and not available in the main document, the main author was
contacted.
A sample search strategy for Scopus is presented with the main
search terms and related terms (Appendix S3). Core search terms were
stroke, guidelines, and TL. Inclusion criteria were as follows:
• CPGs focused on the rehabilitation of stroke populations;
• General stroke CPGs which are not intervention specific (eg, bolus
modification) or discipline specific (ie, produced by individual allied
health groups);
• CPGs making recommendations relating to the intervention of TL
for the management of dysphagia in adults (>18 years) post-stroke;
• CPGs produced between January 2010 and December 2018;
• Most recent versions of CPGs; and
• Published in English.
CPGs should be reviewed or updated regularly, ideally within 3 to
5 years.32-34 This was extended in our study to allow for the time
required to produce and disseminate them by organizations. Titles
and abstracts and guidelines were reviewed by the main author (A.M.)
and those that did not meet the criteria were excluded. The remaining
publications were reviewed independently by three reviewers (A.M.,
M.K., C.R.) and consensus regarding inclusion reached on discussion.
2.2 | Data extraction and analysis
2.2.1 | CPG quality
The methodological quality of the included CPGs was evaluated using
The Appraisal of Guidelines for Research and Evaluation Second Edition
(AGREE-II) tool.35 The AGREE-II has been established internationally as
valid and reliable for quality assessment of CPGs.36,37 To facilitate accu-
rate reporting, the organization websites of included CPGs were visited
to retrieve relevant documentation, for example, evidence tables, work-
ing group declaration of interests, and CPG development frameworks.
Where available, these were used in the evaluation process. The
AGREE-II consists of 23 items that are organized into six domains of
guideline development: scope and purpose, stakeholder involvement,
rigour of development, clarity of presentation, applicability, and editorial
independence. Per the AGREE protocol, four reviewers (A.M., D.L., P.B.,
R.G.) completed the appraisal exercise to minimize variability and opti-
mize validity of results. Each appraiser independently rated the 23 items
and met to agree final ratings for items where discrepancies in scoring
were evident. Each reviewer provided a rationale for their score and
consensus was reached between the four reviewers. Scores across all
domains were converted to percentages for each CPG. The AGREE-II
developers advise against calculating an “average” or “overall” score for
CPGs representing a combination of the six AGREE-II domains as each
domain is considered more individually informative to the user. Thus, a
method previously applied by other authors to determine “high-quality”
was also used, where CPGs achieved a standardized score of ≥50% on
all six domains.38
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2.2.2 | Data extraction and evidence analysis
The AGREE-II does not assess the quality of the CPG content including
the evidentiary bases of recommendations. Thus, the extraction and
evaluation of TL specific recommendations were performed across a
number of domains. These included the specific recommendations, the
evidence supporting the recommendations, grading of the evidence
based on the Criteria for Levels of Evidence Reported (CLER) in the
Canadian Stroke Best Practice Recommendations39 (with additional
categories), and an examination of the appropriateness of the cited evi-
dence. The details of this framework are shown in Appendix S4. Four
reviewers (A.M., D.L., M.K., C.R.) extracted the data, compared the
extractions to ensure comprehensiveness, evaluated the extracted data,
and agreed the class of recommendation, classification of evidence, and
evaluation of included evidence. Results from the AGREE-II tool are
reported as total domain scores in Table 2.
F IGURE 1 Preferred Reporting
of Items for Systematic Reviews
(PRISMA) flowchart. To
demonstrate the process and results
of the literature search, a PRISMA
flowchart was utilized and the
results are presented. The flow
diagram depicts the flow of
information through the different
phases of the systematic review. It
maps out the number of records
identified, included and excluded,
and the reasons for exclusions. The
total number of included papers is
outlined in the last box
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3 | RESULTS
3.1 | Included CPGs
A total of 2460 documents were initially retrieved from searches.
Hand and Google searching retrieved no additional documents. Fol-
lowing removal of duplicates and initial screening of titles and
abstracts, 64 documents were considered for full screening. The
reviewers independently applied the inclusion criteria to the 64 docu-
ments and 13 CPGs were agreed upon for final inclusion (Figure 1)
representing six Northern and Continental European (Germany, Ire-
land, Scotland, United Kingdom), two Australasian (Australia, Philip-
pines), one African (Cameroon), and four North American (Canada,
United States) countries/provinces. The CPG selection process is
summarized in a PRISMA flow diagram (Figure 1).
The included CPGs (Table 1) were published between 2010 and
2018 and are referenced in text by their country of origin and date of
publication. CPGs with the same countries and dates were given added
identification information (eg, Scotland 2010 #119). Six CPGs were ini-
tially sourced through bibliographic databases (Germany 2013, USA
2010, Canada 2015, Canada 2018, Cameroon 2013, USA 2016) and
the remaining sourced through stroke organization and guideline
database websites. For most of those retrieved via bibliographic
searches, full copies of guidelines and supporting documentation were
obtained via the developers' websites. One CPG (Germany 2013) was
primarily evaluated using the journal publication as its authors advised
that the obtained CPG was the only English version available.
3.2 | Quality of CPGS
The CPGs generally scored well, with 7/13 scoring above the >50%
quality threshold in all six domains. The others tended to score vari-
ably across domains with one (Philippines 2010) scoring below this
threshold on all domains. Four of the included CPGs (Australia 2017,
Canada 2015, UK 2013, UK 2016) scored >70% on all domains. Thus,
over half the included CPGs can be considered high-quality CPGs and
nearly a third excellent quality. For all CPGs, the highest scoring
domains (aggregated across all CPGs) were Domain 1: scope and pur-
pose (85%) and Domain 4: clarity of presentation (81.8%). CPGs per-
forming better overall tended to achieve higher scores for all domains
including, for example, Domain 2 (stakeholder involvement) and
Domain 6 (editorial independence). On the basis of AGREE-II evalua-
tions, most CPGs would be recommended for use (Table 2).
TABLE 1 Included stroke CPGs
CPG Developing organization Year Funding/support source
Australia 201740 Stroke Foundation of Australia (SFA) 2017 Australian Government, Department of Health and
Ageing
Disclaimer that final recommendations not influenced
by funding body
Cameroon 201341,42 SEEPD Program of the Cameroon Baptist Convention
Health Board, the Bamenda Coordinating Centre for
Studies in Disability and Rehabilitation (BCCSDR),
and ICDR-Cameroon of the University of Toronto
2013 Not clearly stated
Canada 201543 Heart and Stroke Foundation (HSF-C)/Canadian Stroke
Best Practices Advisory Committee
2015 Canadian Stroke Network and the Heart and Stroke
Foundation
Canada 201844 Heart and Stroke Foundation (HSF-C)/Canadian Stroke
Best Practices Advisory Committee Acute Inpatient
Stroke Care Writing Group
2018 Canadian Stroke Network and the Heart and Stroke
Foundation
Germany 201345 German Nutrition Society (DGEM) German Society for
Neurology, German Geriatric Society
2013 German Nutrition Society (DGEM), German Society for
Neurology, German Geriatric Society
Ireland 201046 Irish Heart Foundation (IHA) 2010 MSD Ireland
Philippines 201047 The Stroke Society of the Philippines (SSP) 2010 Not clearly stated
Scotland 2010 #11848 Scottish Intercollegiate Network (SIGN) 2010 NHS Quality Improvement Scotland
Scotland 2010 #11949 Scottish Intercollegiate Network (SIGN) 2010 NHS Quality Improvement Scotland
UK 201350 National Institute for Clinical Excellence (NICE) 2013 National Institute for Clinical Excellence (NICE)
UK 201629 Royal College of Physicians (RCP) Intercollegiate
Stroke Working Party
2016 Royal College of Physicians Clinical Effectiveness and
Evaluation Unit
USA 201051 Veterans Association/Department of Defence
(VA/DOD)
2010 Office of Quality and Performance VA and Quality
Management Division US Army
USA 201652 American Heart Association (AHA)/American Stroke
Association (ASA)
2016 The American Heart Association/American Stroke
Association
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3.3 | Extraction exercise regarding prescription
recommendations for TL
1. Recommendations: 30 recommendations were extracted from the
included CPGs (Table 3). Of these, 16 recommendations can be
classed as a direct recommendation to use the TL treatment and all
CPGs made this recommendation. However, only a handful of CPGs
(Cameroon 2013, Germany 2013, UK 2016) made an unequivocal
recommendation, with most TL recommendations made in the con-
text of offering a suite of interventions for dysphagia. Other recom-
mendations reflected monitoring of and supporting the intervention
during implementation including referral to dietitians, staff training,
and monitoring of hydration and oral hygiene.
2. Type of evidence supporting TL recommendations: The evidence
cited to support recommendations is given in Tables 3 and 4.
Seven recommendations were not clearly sourced (the authors
were unable to identify the pertaining evidence) and two related
to consistency descriptor frameworks. Of the remaining,
11 (36.6%) were supported by studies of strong design based on
the CLER framework39 and one was based on level 2 evidence.
Seven recommendations (23%) used information retrieved from
other CPGs to support TL recommendations and six (20%)
employed consensus. For Recommendation A (recommendation to
use), moderate-strong research evidence emerged as the primary
evidentiary source. For Recommendation B (monitoring and imple-
mentation of TL) varied sourcing of evidence was evident.
3. Appropriateness of cited evidence supporting TL recommendations: A
number of key studies were consistently referenced to support TL
recommendations with Geeganage et al and Carnaby et al primary
among them.13,59 While some studies extracted were mentioned
explicitly in CPGs, others were embedded in other sources such as
references to other clinical guidelines or evidence summaries. For
example, Scotland 2010 #119 used the Agency for Healthcare
Research and Quality (AHRQ) Evidence Report Summary.68 Use of
TABLE 2 AGREE-II domain scores
Domain 1 Domain 2 Domain 3 Domain 4 Domain 5 Domain 6
CPG %
Scope and
purpose
Stakeholder
involvement
Rigour of
development
Clarity of
presentation Applicability
Editorial
independence
Australia 2017 Domain score 83 97 183 79 102 53
% 98.6 84.4 92.3 93.1 89.6 93.8
Cameroon 2013 Domain score 74 54 90 55 74 17
% 86.1 39.6 36.9 59.7 60.4 18.8
Canada 2015 Domain score 77 103 175 74 87 54
% 90.1 90.6 87.5 86.1 74.0 95.8
Canada 2018 Domain score 76 87 136 74 85 52
% 88.9 74 64.3 86.1 71.9 91.7
Germany 2013 Domain score 54 48 125 72 38 29
% 58.3 33.3 57.5 83.3 22.9 43.8
Ireland 2010 Domain score 62 39 53 53 45 28
% 69.4 24 14.9 56.9 30.2 41.7
Philippines 2010 Domain score 39 42 62 44 38 8
% 37.5 27.1 20.2 44.4 22.9 0
Scotland 2010 #118 Domain score 80 97 167 77 92 34
% 94.4 84.4 82.7 90.3 79.2 54.2
Scotland 2010 #119 Domain score 75 100 167 66 67 46
% 87.5 87.5 82.7 75.0 53.1 79.2
UK 2013 Domain score 83 105 190 78 101 48
% 98.6 92.7 96.4 91.7 88.5 83.3
UK 2016 Domain score 84 98 187 80 104 56
% 100 85.4 94.6 94.4 91.7 100
USA 2010 Domain score 65 63 137 70 77 20
% 90.3 49.0 64.9 80.6 63.5 25.0
USA 2016 Domain score 68 52 154 61 72 45
% 94.4 37.5 75 68.1 58.3 77.1
All Overall 1000 1086 2006 962 1088 528
Domain scores 85.0 69.3 73.1 81.8 69.4 67.4
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evidence to support the intervention of TL as part of a mul-
ticomponent programme tended to be appropriately cited. Apart
from this, there was a mismatch between recommendations and
evidence, with inappropriate evidence being used in a number of
places. Inappropriateness is measured in various ways including
use of non-stroke evidence, evidence not pertaining to the inter-
vention in question, and evidence not providing actual support for
the intervention. A commentary is provided on the validity of the
specific research sources cited in Table 5.
4 | DISCUSSION
This is the first review that examines both the quality of stroke CPGs
and the evidentiary bases of recommendations made regarding the TL
intervention. While nearly half the CPGs that fitted the inclusion criteria
were sourced from bibliographic databases, the remaining were retrieved
from professional association and guideline websites and the documen-
tation required to support the exercise was mostly available on their
websites. This resonates with the ADAPTE Collaboration commentary
that many guideline developers are posting CPGs directly online and not
publishing through peer reviewed bibliographic sources.85 This approach
has both benefits and disadvantages. The advantages include better
accessibility to CPGs by both the general public and clinicians as well as
flexibility to rapidly update online versions with new evidence. However,
unless the processes for developing and updating CPGs are both explicit
and rigorous, they may not be subject to the same peer review process
as for CPGs published in the literature. In this study, a clear underuse of
recent systematic reviews for the intervention was evident for most
CPGs, irrespective of whether they were published through association
websites or in journals. A number of CPGs (eg, UK 2013) have notably
attempted to improve rigour by building in external peer review ele-
ments to the guideline development process.
4.1 | The quality of CPGs
While the quality of stroke CPGs based on the AGREE-II evaluation
was variable, just over half rated as generally good to excellent.
Although there is space for improvement, this reflects well on guide-
line developers attempts to improve process rigour when developing
CPGs,17,27 and is consistent with Rohde et al's recent systematic
review of stroke CPGs and aphasia.86 Domain 1 (scope and purpose)
TABLE 4 Bases of thickened liquid recommendations
Recommendation CPG
Other
guidelines
Research
evidence
Clinical opinion/
consensus
Not
stated
Consistency
descriptor
documents
A. Recommend use of TL Australia 2017 ✓
Cameroon 2013 ✓
Canada 2015 ✓ ✓
Germany 2013 ✓
Ireland 2010 ✓
Philippines 2011 ✓
Scotland 2010 #118 ✓
Scotland 2010 #119 ✓
UK 2013 ✓
UK 2016 ✓ ✓
USA 2010 ✓ ✓
USA 2016 ✓
B. Monitoring and
implementation of TL
Australia 2017 ✓ ✓
Canada 2015 ✓ ✓
Canada 2018 ✓ ✓
Germany 2013 ✓
Ireland 2010 ✓
Scotland 2010 #119 ✓
UK 2013 ✓ ✓ ✓ ✓
UK 2016 ✓ ✓ ✓
USA 2010 ✓
Total sources 9 11 4 5 3
% of all sourcing 28.1% 34.4% 12.5% 15.6% 9.4%
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TABLE 5 Appropriateness of main evidence
Study Comment on evidence
Does study
examine TL
intervention
specifically?
Can effects
of TL be
isolated?
CPGs using
evidence
For which
recommendation
Geeganage et al 201213 Systematic review of dysphagia interventions in stroke.
Based on one RCT—Garon et al 199783 evaluating
hydration in TL and water protocols. No implications
for efficacy of TL can be drawn.
N N Australia 2017 A
Canada 2018 B
Canada 2015 B
UK 2016 A
USA 2016 A
Bakhtiyari et al 201553 Randomized clinical trial. Patients allocated to groups
based on the timing of initiation of swallowing
therapy after the stroke. A range of interventions
used including traditional swallowing therapy.
N N Australia 2017 A
Singh and Hamdy 200684 Recommendations based on guideline which used this
review. Review concludes that while numerous
studies have described the changes in swallowing
physiology in people with stroke taking TL, none
have shown clinical efficacy.
N N Cameroon 2013 A
Carnaby et al 200658 Does not specifically examine TL in isolation but as
multicomponent intervention. The effectiveness of
TL as a treatment cannot be isolated/supported
based on these papers.
Y N Canada 2018 B
Canada 2015 A
Scotland 2010#118 A
UK 2013 A
UK 2016 A
DePippo et al 199459 Three graded levels of dysphagia therapist control of
diet consistency and reinforcement of compensatory
swallowing techniques were provided. No significant
difference between the three treatment groups. The
effectiveness of TL as a treatment cannot be
isolated/supported based on these papers.
Y N Canada 2015 A
Cook and Kahrilas 199964 Literature review. Studies included multicomponent
programmes (Groher, 1987; DePippo et al 1994;
Neumann et al 1993; Neumann et al 1995)
retrospective reviews (Kaspairn et al 1989), varied/
non-stroke patients (Martens et al 1990; Neumann
et al 1993; Silbergleit et al 1991), non-significant
outcomes (eg, Martens et al 1990) and studies
where TL not included (Neumann et al 1995).
Y/N N Scotland 2010 #119 A
Logemann et al 199865 Study examining instrumentation to assess swallow
function.
N N Scotland 2010 #119 A
Elmstahl et al 199966 Observational study reporting on the effects of
swallowing techniques on nutritional and
anthropometric variables. TL included. Found
benefits for multicomponent swallowing therapy.
Y N Scotland 2010 #119 A
USA 2010 A
Huckabee and Cannito
199967
Retrospective review of multicomponent programme
with a group of 10 patients with chronic dysphagia
subsequent to a single brainstem injury.
Y N Scotland 2010 #119 A
Klor et al 199968 Sixteen nursing home patients on PEG feeding post
stroke. Non-randomized study. Multicomponent
programme.
Y N Scotland 2010 #119 A
Rosenbek et al 199669 Thermal intervention (icing). N N Scotland 2010 #119 A
Ramritu et al 200070 Systematic review on nursing interventions for broad
range of paediatric and adult individuals with
dysphagia due to neurological impairment. Limited/
not directly applicable research evidence.
N N Scotland 2010 #119 B
(Continues)
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and Domain 4 (clarity of presentation) were the highest scoring
domains. Furthermore, most CPGs scored well in the Domain 5: rigour
of development, the exceptions being Cameroon 2013, Ireland 2010,
and Philippines 2010. Domain 5 is fundamental to the integrity and
transparency of CPGs and often considered most indicative of CPG
quality.17 Despite this, there was some variability in scoring for
domains both within and between CPGs which suggests ongoing
improvements are required. Scores for some domains may reflect a
lack of availability and/or explicitness on the part of CPG documenta-
tion. In a number of cases, the authors felt unable to credit CPGs with
points on the AGREE-II scoring tool due to a lack of available informa-
tion. This includes Germany 2013 as the only English material avail-
able was the published paper. It is assumed further supporting
documentation would be available in its original language.
4.2 | The evidentiary bases of recommendations
The consensus across all CPGs was that the intervention of TL should
be used for people with aspiration subsequent to stroke, either in
isolation or as part of a general dysphagia treatment programme. The
evidence base pertaining to the intervention of TL is less than robust
and therefore a mismatch between evidence and recommendations is
apparent. Clinicians who access CPGs may do so due to a lack of time
to read, appraise, and synthesize all the available evidence on the
topic, leading to a reliance on CPGs to provide evidence-based recom-
mendations. Therefore, the unequivocal recommendations by the
included CPGs to administer TL for PWD post-stroke are problematic.
This was commonly magnified by the lack of editorial commentaries
highlighting the poor empirical support. The very nature of summation
integral to CPGs may in itself undermine informed clinical decision
making. To investigate recommendation sources, the authors of this
study had to repeatedly perform searches to identify and retrieve
papers not clearly cited. This is not a task busy clinicians can or should
have to perform.
There were difficulties with the evidentiary bases of TL recom-
mendations across most CPGs. In many cases the cited studies did not
clearly provide evidence of efficacy for the treatment of TL. Where
such justification was provided, it was only as part of multi-
component dysphagia programmes. While most recommendations
TABLE 5 (Continued)
Study Comment on evidence
Does study
examine TL
intervention
specifically?
Can effects
of TL be
isolated?
CPGs using
evidence
For which
recommendation
Kertscher et al 201475 Systematic review of bedside screenings in a range of
neurological patients. Variable results.
N N UK 2016 B
Wilson and Howe 201276 Cost effectiveness analysis of VFSS. Investigation of
dysphagia with instrumental assessments helps to
predict outcomes and improve treatment planning.
N N UK 2016 B
Bax et al 201477 Retrospective study. Significant findings in favour of
FEES and reduced rates of pneumonia and return to
standard diet. Negative findings in terms of length of
hospital stay and non-oral feeding
N N UK 2016 B
Speyer et al 201069 Systematic review not specific to stroke. Included a
range of dysphagia interventions. Difficult to draw
strong conclusions about the effectiveness of TL as a
treatment from the reviews.
Y N UK 2016 A
Foley et al 200878 Systematic review found that general dysphagia
therapy programmes are associated with a reduced
risk of pneumonia in the acute stage of stroke.
Concluded that there was limited/inconclusive
evidence.
Y N UK 2016 A
USA 2010 A
Rofes et al 201380 Non-randomized, non-intervention study. Mixed
population. Assessment of specific commercial
product. Positive effects for TL. Commercially
funded.
Y Y UK 2016 A
Bath et al 199981 Systematic review including multicomponent
programmes/multiple interventions/multiple
outcomes. Concluded that there was limited/
inconclusive evidence.
Y N USA 2010 A
Ashford et al 200982 Systematic review regarding behavioural dysphagia
interventions (postural interventions swallowing
manoeuvers) for a range of neurological disorders.
Did not include TL.
N N USA 2016 A
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reflected this—either directly by recommending use of TL as part of
such a programme or by broad statements reflecting a suite of possi-
ble treatments—this evidence does not provide support for the effi-
cacy of the TL treatment. This important caveat was rarely clearly
stated. Other supporting evidence did not relate specifically or wholly
to the population under scrutiny. Examples include Garon et al which
did not specifically examine TL,83 and systematic reviews such as
Speyer et al which examined a range of clinical populations.79 Further-
more, some evidence was used to support recommendations without
relevant context or clarity being provided. An example of this was the
Foley et al systematic review.78 Foley et al plainly summarize that:
“there is scant empirical evidence of its medical effectiveness due to a
number of factors …making it difficult to establish which component
was associated with pulmonary benefit” (p. 262).78 Ideally, when evi-
dence is used to support recommendations, a corresponding note on
the original authors' conclusions should be made to provide context
and ensure clarity in translation.
Two studies in particular were utilized by a number of CPGs. One
was the systematic review of Geeganage et al13 which was effectively
based on a randomized control trial83 which evaluated hydration in TL
and free water protocols (a different intervention), with limited impli-
cations for the efficacy of TL. The other frequently cited paper was
Carnaby et al, an RCT which evaluated a multicomponent dysphagia
programme and from which the effects of TL cannot be isolated.58
Furthermore, the more recently produced GPGs did not tend to
include newer systematic reviews11,12,14,15 including that of Beck et al
who recommended against the use of TL.16 While such deficits may in
part result from the time required to develop and produce new ver-
sions of guidelines, an efficient process for retrieving and including
most recent research is warranted to reflect the most up-to-date evi-
dence. Martínez García et al noted that such a mechanism is impera-
tive given their findings that CPG recommendations quickly become
outdated, with one out of five recommendations being out of date
after 3 years.87 Protocols for removing outdated CPGs from circula-
tion are therefore also warranted. In many cases, previous versions of
the included CPGs were still available and a number of “older” CPGs
were still in use.
The employment by guideline developers of other CPGs as
sources of evidence and support for recommendations was also
noted. This reliance can be understood to be less than ideal, especially
in the context of the findings from this study. Furthermore, the range
of sources to support recommendations was generally not extensive
and did not always reflect the ideal triad of evidence from practice
and patient perspectives. Where consensus was employed, this usu-
ally reflected consensus within the working group and not a broader
representation of individuals directly involved in prescribing and
implementing highlighted interventions.23 There also tended to be
poor consideration of other important factors such as contextual evi-
dence which has been clearly shown to factor in treatment implemen-
tation in a number of health disciplines.88,89 Furthermore,
contemplation of patient and ethics-based evidence including possible
treatment burden and intervention risks and benefits were generally
absent. This is especially important for interventions such as TL where
there is clear evidence of patient dislike and treatment adherence
issues.7 It is reasonable to argue that CPG recommendations should
be better grounded in a range of information and evidence and frame-
works such as the total evidence and knowledge approach90 may help
in this regard. This may be especially so in the cases of interventions
with limited empirical evidence such as TL.
What can be positively inferred is the attempt by most CPGs
working groups to systematically review the evidence. Furthermore,
some CPGs do provide recommendation rationales. Scotland 2010
#119, for example, notes that despite the sparse available data, it
seems “prudent” to include dysphagia-specific management as part of
the standard protocol of stroke management in the acute care setting:
“Diet modification has been shown to be effective in specific individ-
uals using video-fluoroscopy and is standard management of dyspha-
gia following stroke” (p. 12).49 It is clear most of the CPGs involved
are attempting to make “best” recommendations in the context of lim-
ited research evidence. However, the misappropriation of evidence,
non-use of recent evidence, limited use of a range of evidence, and
the failure to clearly report the state of the evidence when rec-
ommending TL raises questions about the reliability of CPG recom-
mendations. It seems true, as Elwyn et al have noted, that “the reality
is that busy clinicians are working with guidelines that represent
imperfect knowledge” (p. 2). 91 Irrespective, guideline developers have
a responsibility to make truly evidence based recommendations, use
up-to-date evidence, be explicit about the strengths and limitations of
the evidence they use to support their recommendations, and use that
evidence appropriately.
5 | RECOMMENDATIONS
5.1 | For guideline developers
• Guideline developers should make reasonable efforts to employ
the best and most recent evidence when making recommendations
and CPGs should preface intervention-specific recommendations
with clear summaries of the evidence-base.
• Supporting evidence should be specific to the intervention being
recommended. Furthermore, explicit links between supporting evi-
dence and individual recommendations should be consistently
employed to enable readers to assess the evidence and encourage
guideline developers to provide targeted evidence for specific
recommendations.
• Clear directions and easy access to all supporting documentation
are required to enable future researchers and policy makers to fully
understand the evidence on which recommendations are being
made, including caveats to recommendations.
• A broader range of evidence should be considered in formulating
recommendations especially in cases where the intervention evi-
dence is limited. This may include ethical, contextual, and collective
patient evidence.
• Guidelines developers should consider the use of expert panels
with intervention-specific expertise when evaluating evidence and
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making and reviewing recommendations. Where recommendations
are based on such evidence, this should be explicitly stated to
ensure readers understand the nature of the evidence supporting
that recommendation and can act accordingly.
• Care should be taken to ensure that traditional clinical practices
are not automatically recommended or assumed to be best practice
in the absence of supporting evidence.
• To ensure that publicly available guidelines remain current, processes
for updating CPGs need to be explicit and rigorous. For example, UK
2013 CPG authors designed ongoing external peer review elements
to their guideline development process. A process for removal or
CPGs is also indicated based on the findings of this review.
5.2 | For individuals and organizations
employing CPGs
• Individuals, teams, and organizations employing CPGs should be
aware that CPG recommendations may not be wholly evidence-
based and should review the evidence where possible to ensure
recommendations are evidence-based.
• Clinicians may benefit from training in CPG critical appraisal in
order to be able to evaluate the supporting evidence used by
CPGs. Such investments would maximize the applicability of CPGs
as well as increase the number of clinicians who may, in the future,
contribute to CPG content themselves.
6 | STRENGTHS AND LIMITATIONS
Systematic methods were used to identify, select, appraise, and syn-
thesize the findings from the included CPGs. The PRISMA standard-
ized reporting guidelines were referenced to illustrate the flow of
studies in the review. The interdisciplinary review team reflected a
mix of academics and clinicians. This is first review to examine the evi-
dence underpinning recommendations in stroke CPGs.
Some limitations are evident. Comparatively, this review includes
a small sample size. Possible explanations for this include the use of
TL as a core term in the search string and the timeframe imposed to
maximize retrieval of the most current versions of CPGs. Additionally,
although it is advised that CPGs are updated every 3 to 5 years, this
was not the case for a number of CPGs in the review. This means that
some included CPGs could not reflect up to date evidence. Further-
more, the inclusion criteria did not capture CPGs published by profes-
sional speech and language therapy associations which may reflect
deeper discipline-specific knowledge regarding the research evidence
and the intervention itself. This may limit the external validity of the
findings. Where possible the evidence referred to in “other guidelines”
was also extracted. In some cases this was not possible due to guide-
line age, lack of access to original documentation or being superseded
by a subsequent guideline. Some CPGs, such as Germany 2013, may
not have been best reflected in this exercise due to lack of accessibil-
ity to guideline development documents.
7 | CONCLUSION
This study examined the evidentiary bases of recommendations for
the intervention of TL for PWD post-stroke. The quality of the
13 stroke CPGs included in this study was generally good, based on
tools examining the development of those guidelines. A discrepancy
was highlighted between quality rating tools for guidelines and the
narrative evaluation of the evidence underpinning guideline recom-
mendations. Despite the limited evidence base for the TL interven-
tion, there was consensus evident among CPGs in recommending
it. Furthermore, much of the evidence used to support recommenda-
tions was inappropriate, suggesting less than satisfactory evidence-
based practices in formulating recommendations. CPGs may therefore
not be the most reliable decision support tools with which to facilitate
evidence based clinical decision making and clinicians may be better
served by guidelines that target specific interventions rather than
broad-based instruments. Furthermore, if these findings are reflected
for other interventions and in other CPGs, questions should be raised
about the value and reliability of guidelines generally.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
ORCID
Arlene McCurtin https://orcid.org/0000-0002-0649-0448
REFERENCES
1. Altman KW, Yu G, Schaefer SD. Consequences of dysphagia in the
hospitalized patient, impact on prognosis and hospital resources. Arch
Otolaryngol. 2010;136:784-789.
2. Arnold M, Liesirova K, Broeg-Morvay A, et al. Dysphagia in acute
stroke: incidence, burden and impact on clinical outcome. PLoS One.
2016. https://doi.org/10.1371/journal.pone.0148424.
3. Doggett DL, Tappe KA, Mitchell MD, Chapell VC, Turkelson CM. Pre-
vention of pneumonia in elderly stroke patients by systematic diagno-
sis and treatment of dysphagia: an evidence based comprehensive
analysis of the literature. Dysphagia. 2001;16:279-295.
4. Armstrong JR, Mosher BD. Aspiration pneumonia after stroke inter-
vention and prevention. Neurohospitalist. 2011;1(2):85-93.
5. Martino R, Foley N, Bhoghal S, Diamant N, Speechley M, Teasell R.
Dysphagia after stroke; incidence, diagnosis, and pulmonary complica-
tions. Stroke. 2005;36:2756-2763.
6. Clavé P, de Kraa M, Arreola V, et al. The effect of bolus viscosity on
swallowing function in neurogenic dysphagia'. Aliment Pharmacol.
2006;24(9):1385-1394.
7. McCurtin A, Healy C, Kelly L, Murphy F, Ryan J, Walsh J. Plugging the
patient evidence gap: what patients with swallowing disorders post-
stroke say about thickened liquids. Int J Lang Commun Disord. 2018;
53(1):30-39.
8. Jones O, Cartwright J, Whitworth A, Cocks N. Dysphagia therapy
post stroke: an exploration of the practices and clinical decision-
making of speech-language pathologists in Australia. Int J Speech Lang
Pathol. 2017. https://doi.org/10.1080/17549507.2016.1265588.
9. McCurtin A, Healy C. Why do clinicians choose the therapies and
techniques they do? Exploring clinical decision making via treatment
selections in dysphagia practice. J Speech Lang Pathol. 2017;19(1):
69-76.
10. Smithard DG, Fairfield C, Roffe C, Enderby P. European Society for
Swallowing Disorders Position Statements and Meeting Abstracts
14 MCCURTIN ET AL.
2012: dysphagia management in the acute phase of stroke. Dyspha-
gia. 2007;28(2):307.
11. Andersen UT, Beck AM, Kjaersgaard A, Hansen T, Poulsen I. System-
atic review and evidence based recommendations on texture modi-
fied foods and thickened fluids for adults (≥18 years) with
oropharyngeal dysphagia. e-SPEN J. 2013;8(4):127-134.
12. Newman R, Vilardell N, Clave P, Speyer R. Effect of bolus viscosity on
the safety and efficacy of swallowing and the kinematics of the swal-
low response in patients with oropharyngeal dysphagia: white paper
by the European Society for Swallowing Disorders. Dysphagia. 2016;
31:232-249.
13. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dys-
phagia and nutritional support in acute and subacute stroke. Cochrane
Database Syst Rev. 2012. https://doi.org/10.1002/14651858.
CD000323.pub2.
14. Kaneoka A, Pisegna JM, Saito H, et al. A systematic review and meta-
analysis of pneumonia associated with thin liquid vs. thickened liquid
intake in patients who aspirate. Clin Rehabil. 2016. https://doi.org/10.
1177/0269215516677739.
15. Steele CM, Alsanei WA, Ayanikalath S, Brabon CE, Chen J, et al. The
influence of food texture and liquid consistency modification on
swallowing physiology and function: a systematic review. Dysphagia.
2015;30:2-6.
16. Beck AM, Kjaersgaard A, Hansen T, Poulsen I. Systematic review and
evidence based recommendations on texture modified foods and
thickened liquids for adults (above 17 years) with oropharyngeal dys-
phagia – an updated clinical guideline. Clin Nutr. 2017;37:1980-1991.
https://doi.org/10.1016/j.clnu.2017.09.002.
17. Hurdowar A, Graham ID, Bayley M, Harrison M, Wood-Dauphinee S,
Bhogal S. Quality of stroke rehabilitation clinical practice guidelines.
J Eval Clin Pract. 2007;13:657-664.
18. Kredo T, Bernhardsson S, Machingaidze S, et al. Guide to clinical prac-
tice guidelines: the current state of play. Int J Qual Health Care. 2016;
28(1):122-128.
19. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical
guidelines: potential benefits, limitations, and harms of clinical guide-
lines. BMJ. 1999;318(7182):527-530.
20. Heiwe S, Kajermo KN, Tyni-Lenné R, et al. Evidence-based practice:
attitudes, knowledge, and behaviour among allied health care profes-
sionals. Int J Qual Health Care. 2011;23(2):198-209.
21. Management of Stroke Rehabilitation Working Group. VA/DOD clini-
cal practice guideline for the management of stroke rehabilitation.
J Rehabil Res Dev. 2010;47(9):1-43.
22. Wainberg SK, Santos NCL, Gabriel FC, et al. Clinical practice guide-
lines for surgical antimicrobial prophylaxis: qualitative appraisals and
synthesis of recommendations. J Eval Clin Pract. 2018. https://doi.
org/10.1111/jep.12992.
23. Clifford AM, Ryan J, Walsh C, McCurtin A. What information is used
in treatment decision aids? A systematic review of the types of evi-
dence populating health decision aids. BMC Med Inform Decis. 2017.
https://doi.org/10.1186/s12911-017-0415-7.
24. Murray J, Miller M, Doeltgen S, Scholten I. Intake of thickened liquids
by hospitalized adults with dysphagia after stroke. Int J Speech Lang
Pathol. 2014;16(5):486-494.
25. Alonso-Coello P, Irfan A, Solà I, et al. The quality of clinical practice
guidelines over the last two decades: a systematic review of guideline
appraisal studies. Qual Saf Health Care. 2010;19(6):e58.
26. Siering U, Eikermann M, Hausner E, Hoffmann-Eßer W,
Neugebauer EA. Appraisal tools for clinical practice guidelines: a sys-
tematic review. PLoS One. 2013. https://doi.org/10.1371/journal.
pone.0082915.
27. Navarro Puerto MA, Ibarluzea IG, Ruiz OG, et al. Analysis of the qual-
ity of clinical practice guidelines on established ischemic stroke. Int J
Technol Assess. 2008;24(3):333-341.
28. Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF.
Conflicts of interest and the quality of recommendations in clinical
guidelines. J Eval Clin Pract. 2012;19(4):674-681.
29. Royal College of Physicians in London & Intercollegiate Stroke Work-
ing Party. National clinical guideline for stroke. 5th ed.; 2016 https://
www.rcplondon.ac.uk/guidelines-policy/stroke-guidelines. Accessed
June 21, 2017.
30. Gandhi S, Verma S, Ethier JL, Simmons CE, Burnett H, Alibhai SM. A
systemic review and quality appraisal of international guidelines for
early breast cancer systemic therapy: are recommendations sensitive
to different global resources? Breast. 2015;24:309-317.
31. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA group. Pre-
ferred reporting items for systematic reviews and meta-analyses: the
PRISMA statement. PLoS Med. 2009. https://doi.org/10.1371/
journal.pmed.1000097.
32. Martínez García L, Arévalo-Rodríguez I, Solà I, et al. Guidelines for
monitoring and updating clinical practice guidelines: a systematic
review. Implement Sci. 2012. https://doi.org/10.1186/1748-5908-
7-109.
33. Silagy C, Rubin G, Henderson-Smart D, Gross P. A guide to the devel-
opment, implementation and evaluation of clinical practice guidelines.
National Health and Medical Research Council. Canberra: Common-
wealth of Australia; 1998:1-79.
34. RWM V, Sanabria AJ, Solà I, Alonso-Coello P, Martínez García L.
Guidance for updating clinical practice guidelines: a systematic review
of methodological handbooks. Implement Sci. 2014. https://doi.org/
10.1186/1748-5908-9-3.
35. AGREE Next Steps Consortium. The AGREE II Instrument [online];
2009. http://www.agreetrust.org/wp-content/uploads/2013/10/
AGREE-II-Users-Manual-and-23-item-Instrument_2009_UPDATE_
2013.pdf. Accessed June 20, 2017.
36. Brouwers MC, Kho ME, Browman GP, et al. Development of the
AGREE II, part 1: performance, usefulness and areas for improvement.
Can Med Assoc J. 2010a;182(10):1045-1052.
37. Brouwers MC, Kho ME, Browman GP, et al. Development of the
AGREE II, part 2: assessment of validity of items and tools to support
application. Can Med Assoc J. 2010b;182(10):472-478.
38. Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, Tam KW. Systematic
review of clinical practice guidelines in the diagnosis and management
of thyroid nodules and cancer. BMC Med. 2013. https://doi.org/10.
1186/1741-7015-11-191.
39. Teasell R, Foley N, Salter K, Bhogal S, Jutai J, Speechley M. Evidence-
based review of stroke rehabilitation: executive summary, 12th edi-
tion. Top Stroke Rehabil. 2009;16(6):463-488.
40. Stroke Foundation of Australia. National Stroke Foundation: Clinical
Guidelines for Stroke Management. Melbourne: National Stroke Foun-
dation; 2017 https://informme.org.au/Guidelines/Clinical-Guidelines-
for-Stroke-Management-2017. Accessed December 20, 2017.
41. NWR Best Practices in Stroke Rehabilitation Group Best Practice
Guidelines for the Management and Rehabilitation of Stroke in the
North West Region of Cameroon; 2013. http://icdr.utoronto.ca/wp-
content/uploads/2015/05/Best-Practice-Guideline-Stroke-
rehabilitation-for-NWR-Final-.pdf. Accessed December 20, 2017.
42. Cockburn L, Fanfon TN, Bramall A, et al. Best practice guidelines for
stroke in Cameroon: an innovative and participatory knowledge
translation project. Afr J Disabil. 2014. https://doi.org/10.4102/ajod.
v3i1.92.
43. Hebert D, Lindsay MP, McIntyre A, et al. Canadian stroke best prac-
tice recommendations: stroke rehabilitation practice guidelines,
update 2015. Int J Stroke. 2016;11(4):459-484.
44. Boulanger JM, Lindsay MP, Stotts G, et al. Canadian stroke best prac-
tice recommendations for acute stroke management: prehospital,
emergency department, and acute inpatient stroke care, 6th edition,
update 2018. Int J Stroke. 2018;13(9):949-984.
MCCURTIN ET AL. 15
45. Wirth R, Smoliner C, Jäger M, Warnecke T, Leischker AH, Dziewas R.
Guideline clinical nutrition in patients with stroke'. Exp Transl Stroke
Med. 2014. https://doi.org/10.1186/2040-7378-5-14.
46. Irish Heart Foundation: Council for Stroke. National Clinical Guidelines
and Recommendations for the Care of People with Stroke and Transient
Ischaemic Attack. Dublin: Irish Heart Foundation; 2010 http://
irishheart.ie/wp-content/uploads/2017/04/guidelines.pdf. Accessed
December 20, 2017.
47. Stroke Society of the Philippines. Guidelines for the Prevention, Treat-
ment and Rehabilitation of Stroke. 5th ed. Manila: The Stroke Society
of the Philippines; 2010 http://www.strokesocietyphil.org/files/
2011.pdf. Accessed January 2, 2018.
48. Scottish Intercollegiate Guideline Network. Management of Patients
with Stroke; Rehabilitation, Prevention and Management of Complica-
tions, and Discharge Planning. Edinburgh: Scottish Intercollegiate
Guideline Network; 2010 (SIGN Publication no. 118). www.sign.ac.
uk. Accessed January 2, 2018.
49. Scottish Intercollegiate Guideline Network. Management of Patients
with Stroke: Identification and Management of Dysphagia. Edinburgh:
Scottish Intercollegiate Guideline Network; 2010 (SIGN Publication
no. 119). www.sign.ac.uk. Accessed January 2, 2018.
50. National Institute for Clinical Excellence & National Clinical Guideline
Centre. Stroke rehabilitation: Long term rehabilitation after stroke.
Clinical guideline 162; 2013. https://www.nice.org.uk/guidance/
cg162/resources/cg162-stroke-rehabilitation-full-guideline3.
Accessed January 2, 2018.
51. VA/DoD Clinical Practice Guideline. Management of Stroke Rehabili-
tation; 2010. Washington: Department of Veterans Affairs, Depart-
ment of Defense and The American Heart Association/American
Stroke Association. https://www.healthquality.va.gov/guidelines/
rehab/stroke. Accessed January 4, 2018.
52. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke reha-
bilitation and recovery: a guideline for healthcare professionals from
the American Heart Association/American Stroke Association. Stroke.
2016;47. https://doi.org/10.1161/STR.0000000000000098.
53. Bakhtiyari J, Sarraf P, Nakhostin-Ansari N, et al. Effects of early inter-
vention of swallowing therapy on recovery from dysphagia following
stroke. Iran J Neurol. 2015;14(3):119-124.
54. Cichero JAY, Lam P, Steele CM, et al. Development of international
terminology and definitions for texture-modified foods and thickened
fluids use in dysphagia management. Dysphagia. 2017. https://doi.
org/10.1007/s00455-016-9758-y.
55. Bayley M, Lindsay P, Teasell R, et al. Canadian Stroke Quality of Care
Study: quality indicators for stroke rehabilitation (in collaboration with
SCORE). Toronto, ON: Canadian Stroke Network, Ontario Ministry of
Health and Long-Term Care and Institute for Clinical Evaluative Sci-
ences; 2006.
56. Lindsay MP, Gubitz G, Bayley M, et al. Canadian Best Practice Recom-
mendations for Stroke Care (Update 2010). Ottawa, ON, Canadian
Stroke Network; 2010 http://strokebestpractices.ca/wp-content/
uploads/2010/12/2010_BP_ENG.pdf. Accessed August 31, 2017.
57. SCORE (Stroke Canada Optimization of Rehabilitation through Evi-
dence). Evidence-based Recommendations for the Upper and Lower
Extremities and Risk Assessment Post-stroke. Ottawa, ON: Canadian
Stroke Network; 2007, 2007.
58. Carnaby G, Hankey GJ, Pizzi J. Behavioural intervention for dysphagia
in acute stroke: a randomised controlled trial. Lancet Neurol. 2006;5
(1):31-37.
59. DePippo KL, Holas MA, Reding MJ, Mandel FS, Lesser ML. Dysphagia
therapy following stroke: a controlled trial. Neurology. 1994;44(9):
1655-1660.
60. Stroke Foundation of Australia. National Stroke Foundation: Clinical
Guidelines for Stroke Management. Melbourne: National Stroke Foun-
dation; 2010 https://www.pedro.org.au/wp-content/uploads/CPG_
stroke.pdf. Accessed March 23, 2018.
61. Intercollegiate Stroke Working Party. National Clinical Guideline for
Stroke. 4th ed. London: Royal College of Physicians; 2012 https://
www.strokeaudit.org/Guideline/Historical-Guideline/National-Clinical-
Guidelines-for-Stroke-fourth-edi.aspx. Accessed March 24, 2018.
62. Scottish Intercollegiate Guideline Network. Management of Patients
with Stroke. Edinburgh: Scottish Intercollegiate Guideline Network;
2004 (SIGN Publication no. 119). www.sign.ac.uk/sign-119-
management-of-patients-with-stroke-identification-and-
management-of-dysphagia.html. Accessed March 30, 2018.
63. AHRQ Evidence Report Summaries; 1999. Rockville, MD: Agency for
Healthcare Research and Quality (US); 1998-2005. https://www.
ncbi.nlm.nih.gov/books/NBK11926/#A130265. Accessed March
30, 2018.
64. Cook IJ, Kahrilas PJ. AGA technical review on management of oro-
pharyngeal dysphagia. Gastroenterology. 1999;116:455-478.
65. Logemann JA, Rademaker AW, Pauloski BR, Ohmae Y, Kahrilas PJ.
Normal swallowing physiology as viewed by videofluoroscopy and
videoendoscopy. Folia Phoniatr Logop. 1998;50(6):311-319.
66. Elmstahl S, Bulow M, Ekberg O, Petersson M, Tegner H. Treatment of
dysphagia improves nutritional conditions in stroke patients. Dyspha-
gia. 1999;14(2):61-66.
67. Huckabee ML, Cannito MP. Outcomes of swallowing rehabilitation in
chronic brainstem dysphagia: a retrospective evaluation. Dysphagia.
1999;14:93-109.
68. Klor BM, Militani FJ. Rehabilitation of neurogenic dysphagia with per-
cutaneous endoscopic gastrostomy. Dysphagia. 1999;14:162-164.
69. Rosenbek JC, Roecker EB, Wood JL, Robbins J. Thermal application
reduces the duration of stage transition in dysphagia after stroke.
Dysphagia. 1996;11(4):225-233.
70. Ramritu P, Finlayson K, Mitchell A, Croft G. Identification and Nursing
Management of Dysphagia in Individuals with Neurological Impairment:
A Systematic Review. No. 8. Adelaide: Joanna Briggs Institute for Evi-
dence Based Nursing and Midwifery; 2000.
71. National Institute for Health and Clinical Excellence (NICE). Nutrition
Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and
Parenteral Nutrition. Clinical Guideline 32. London: National Institute
for Health and Clinical Excellence; 2006 https://www.ncbi.nlm.nih.
gov/pubmed/21309138. Accessed April 3, 2018.
72. National Institute for Health and Clinical Excellence (NICE). Diagnosis
and Initial Management of Acute Stroke and Transient Ischaemic Attack
(TIA). Clinical Guideline 68. London: National Institute for Health and
Clinical Excellence; 2008 https://www.niceorguk/guidance/cg68
Accessed April 3, 2018.
73. British Dietetic Association and the Royal College of Speech and Lan-
guage Therapists joint document. National Descriptors for Texture
Modification in Adults; 2002. http://www.bda.uk.com/Downloads/
dysphagia.pdf. Accessed April 4, 2018.
74. NHS National Patient Safety Agency, Royal College of Speech and
Language Therapists, The British Dietetic Association, National
Nurses Nutrition Group and Hospital Caterers Association. Dysphagia
Diet Food Texture Descriptors; 2011. https://www.rcslt.org/
members/publications/dysphagia_diet_texture_descriptions.
Accessed April 4, 2018.
75. Kertscher B, Speyer R, Palmieri M, Plant C. Bedside screening to
detect oropharyngeal dysphagia in patients with neurological disor-
ders: an updated systematic review. Dysphagia. 2014;29:204-212.
76. Wilson RD, Howe EC. A cost-effectiveness analysis of screening
methods for dysphagia after stroke. PM R. 2014;4:273-282.
77. Bax L, McFarlane M, Green E, Miles A. Speech-language pathologist-
led fiberoptic endoscopic evaluation of swallowing: functional out-
comes for patients after stroke. J Stroke Cerebrovasc Dis. 2014;23:
e195–e200.
78. Foley N, Teasell R, Salter K, Kruger E, Martino R. Dysphagia treat-
ment post stroke: a systematic review of randomised controlled trials.
Age Ageing. 2008;37(3):258-264.
16 MCCURTIN ET AL.
79. Speyer R, Baijens L, Heijnen M, Zwijnenberg I. Effects of therapy in
oropharyngeal dysphagia by speech and language therapists: a sys-
tematic review. Dysphagia. 2010;25(1):40-65.
80. Rofes L, Arreola V, Mukherjee R, et al. The effects of a xanthan gum-
based thickener on the swallowing function of patients with dyspha-
gia. Aliment Pharmacol. 2014;39:1169-1170.
81. Bath PM, Bath-Hextall FJ, Smithard D. Interventions for dysphagia in
acute stroke. Cochrane Database Syst Rev. 2009;4:CD00w0323.
82. Ashford J, McCabe D, Wheeler-Hegland K, et al. Evidence-based sys-
tematic review: oropharyngeal dysphagia behavioral treatments, part
III: impact of dysphagia treatments on populations with neurological
disorders. J Rehabil Res Dev. 2009;46:195-204.
83. Garon BR, Engle M, Ormiston C. A randomized control study to
determine the effects of unlimited oral intake of water in patients
with identified aspiration. Neurorehabil Neural Repair. 1997;11(3):
139-148.
84. Singh S, Hamdy S. Dysphagia in stroke patients. Postgrad Med J.
2006;82(968):383-391.
85. ADAPTE Collaboration. The ADAPTE process: resource toolkit for
guideline adaptation. Version 2.0; 2009. http://www.g-i-n.net/
document-store/working-groups-documents/adaptation/adapte-
resource-toolkit-guideline-adaptation-2-0.pdf. Accessed August
7, 2017.
86. Rohde A, Worrall L, Le Dorze G. Systematic review of the quality of
clinical guidelines for aphasia in stroke management: clinical guide-
lines for aphasia. J Eval Clin Pract. 2013;19(6):994-1003.
87. Martínez García L, Sanabria AJ, García Alvarez E, et al. The validity of
recommendations from clinical guidelines: a survival analysis. Can
Med Assoc J. 2014;186(16):1211-1219.
88. McCurtin A, Clifford A. What are the primary influences on treatment
decisions? How does this reflect on evidence-based practice? Indica-
tions from the discipline of Speech & Language Therapy. J Eval Clin
Pract. 2015;21:1178-1189.
89. Parahoo K. Barriers to, and facilitators of, research utilization among
nurses in Northern Ireland. J Adv Nurs. 2000;31(1):89-98.
90. McCurtin A, Murphy CA, Roddam H. Moving beyond traditional
understandings of evidence based practice: a total evidence and
knowledge approach (TEKA) to treatment evaluation and clinical
decision-making in speech-language pathology. Semin Speech Lang.
2019;40(5):370-393.
91. Elwyn E, Wieringa S, Greenhalgh T. Clinical encounters in the post-
guidelines era. BMJ. 2016. https://doi.org/10.1136/bmj.i3200.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article:McCurtin A, Boland P, Kavanagh M,
Lisiecka D, Roche C, Galvin R. Do stroke clinical practice
guideline recommendations for the intervention of thickened
liquids for aspiration support evidence based decision making?
A systematic review and narrative synthesis. J Eval Clin Pract.
2020;1–17. https://doi.org/10.1111/jep.13372
MCCURTIN ET AL. 17
